Safety and Effectiveness Evaluation of the Sinusway Device for Endoscopy of the Nasal Cavity and Paranasal Sinuses
1 other identifier
interventional
17
2 countries
2
Brief Summary
3NT flexible endoscope is a single-use disposable handheld endoscope that provides a means to visualize the nasal cavity and paranasal sinus space and deliver irrigation to treat the sinus ostia and spaces within the paranasal sinus cavities for diagnostic and therapeutic procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2015
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2015
CompletedFirst Posted
Study publicly available on registry
July 20, 2015
CompletedStudy Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedDecember 22, 2017
January 1, 2017
1.7 years
July 13, 2015
December 20, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Safety assessed by unanticipated device-related adverse events
During hospital stay, up to 1 day
Secondary Outcomes (1)
Performance assessed by anatomical landmarks reached and visualized will be recorded
During procedure, up to 3 hours
Study Arms (1)
3NT flexible endoscope
EXPERIMENTALEvaluation of 3NT flexible endoscope in terms of access and evaluation of the nasal anatomy
Interventions
The nasal anatomy will be accessed and viewed with the device during functional endoscopic sinus surgery (FESS) procedure.
Eligibility Criteria
You may qualify if:
- Male or female patient indicated for primary FESS procedure by the ear, nose and throat (ENT) specialist
- Patient age: adult (\>18 years old)
- Patients in general good health in the opinion of the investigator as determined by medical history physical examination
- A patient who is able to understand the requirements of the study, is willing to comply with its instructions and schedules, and agrees to sign the informed consent
You may not qualify if:
- A patient with nasal polyposis
- A patient indicated for tumor excision
- Known history of any significant medical disorder, which in the investigator's judgment contraindicates the patient's participation
- Patients with known current or previous bleeding disorder receiving anticoagulants (e.g., chronic Coumadin treatment)
- Pregnancy
- Patients with previous FESS surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- 3NT Medical Ltd.lead
Study Sites (2)
Ghent University
Ghent, 9000, Belgium
Assuta Medical Center
Tel Aviv, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2015
First Posted
July 20, 2015
Study Start
August 1, 2015
Primary Completion
April 1, 2017
Study Completion
June 1, 2017
Last Updated
December 22, 2017
Record last verified: 2017-01